Clintegration is a new partnership venture from SoftSyl Technologies, a provider of inbound and outbound VoiceXML (News - Alert)-based interactive voice response (IVR) technology, and Endign, a provider of purpose built pharmaceutical solutions, created to provide enterprise scale IVRs and Interactive Web Response (IWRs) capabilities for clinical trials.

Clintegration offers a platform that helps customers build customized interactive Web response (IWR) or interactive voice response (IVR) system with just a few clicks. Collectively, these systems are called interactive response technology (IRT) systems.

The partnership brings IRT systems to clinical trials in the pharmaceutical industry. It combines the expertise of SoftSyl’s proven proprietary technology platform and nationwide client base and Endign’s solid pharmaceutical industry experience.

The cloud-based IRT solutions from Clintegration boast inbound and outbound calling technology and Web-driven services via an underlying industry-compliant VoiceXML platform.  These IRT systems offer site and subject management, screening, enrollment, randomization and ePRO support.  Designed for clinical research organizations (CROs) and Sponsors, these outsourced turn-key IRT solutions automate clinical trials in record time.

With Clintegration IRT, CROs can leverage powerful real-time visual analytics to monitor every aspect of clinical trials. As an outsourced strategic business partner to CROs and Sponsors, the company offers convenient state-of-the-art technology that is already in use at major companies at competitive price point.

Recently SoftSyl Technologies announced the release of a new outbound calling platform that leverages industry-compliant VoiceXML technology. CallPunch joins the company's existing portfolio of offerings that are currently used in a wide variety of call centers and other businesses nationwide.